文献速递肝病

声辐射力脉冲成像测量脾硬度可预测肝硬化患者死亡与肝功能失代偿

Measurement of Spleen Stiffness With Acoustic Radiation Force Impulse Imaging Predicts Mortality and Hepatic Decompensation in Patients With Liver Cirrhosis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2016-12-23

在日本一家医院纳入393例肝硬化患者,其中代偿期280例、失代偿期113例,每3或6个月进行生化、声辐射力脉冲成像、超声及内镜检查,中位随访44.6个月。脾硬度是死亡和失代偿的独立相关因素,预测死亡和失代偿的C指数分别为0.824和0.843。脾硬度截断值3.43 m/s预测死亡的阴性预测值为95.3%、准确度为75.8%;截断值3.25 m/s预测失代偿的阴性预测值为98.8%、准确度为68.9%。

要点

  • 脾硬度是肝硬化患者死亡和肝功能失代偿的独立相关因素(P < .001)。
  • 脾硬度预测死亡和失代偿的C指数分别为0.824和0.843,优于其他参数。
  • 脾硬度3.43 m/s预测死亡的阴性预测值为95.3%、准确度为75.8%。

核心结论

  • 声辐射力脉冲成像测量的脾硬度可预测肝硬化患者死亡,准确度接近76%,预测肝功能失代偿的准确度接近70%。
  • 脾硬度可能是一种有用的无创检查,用于预测患者结局。

研究设计与样本

  • 在日本一家医院纳入393例诊断为肝硬化的患者(基于组织学或体格、实验室及影像学检查),其中代偿期280例、失代偿期113例,纳入时间为2010年9月至2013年8月。
  • 患者每3或6个月接受生化、声辐射力脉冲成像、超声及内镜检查以筛查肝脏相关并发症,直至死亡、肝移植或研究终点(2015年10月)。
  • 主要结局为脾硬度预测死亡和失代偿的准确度,采用Cox比例风险模型分析;采用Harrell C指数分析比较脾硬度与其他无创参数。

主要发现

  • 中位随访44.6个月期间,67例患者死亡,35例患者发生肝功能失代偿。
  • 多因素分析中,调整丙氨酸氨基转移酶、血清钠和终末期肝病模型评分后,脾硬度是与死亡相关的独立参数(P < .001)。
  • 调整Child-Pugh评分和终末期肝病模型评分后,脾硬度与失代偿独立相关(P < .001)。
  • 脾硬度预测死亡和失代偿的准确度高于其他参数,预测死亡和失代偿的C指数分别为0.824和0.843。
  • 脾硬度截断值3.43 m/s预测患者死亡的阴性预测值为95.3%、准确度为75.8%;截断值3.25 m/s预测患者失代偿的阴性预测值为98.8%、准确度为68.9%。

关键数值与推荐

  • 脾硬度截断值3.43 m/s预测死亡的阴性预测值为95.3%、准确度为75.8%。
  • 脾硬度截断值3.25 m/s预测失代偿的阴性预测值为98.8%、准确度为68.9%。
  • 脾硬度预测死亡和失代偿的C指数分别为0.824和0.843。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Hepatic venous pressure gradient can predict mortality and hepatic decompensation in patients with cirrhosis. Measurement of hepatic venous pressure gradient requires an invasive procedure; therefore, prognostic markers are needed that do not require invasive procedures. We investigated whether measurements of spleen stiffness, made by acoustic radiation force impulse (ARFI) imaging, associated with mortality and decompensation in patients with cirrhosis, compared with liver stiffness and other markers. METHODS: We measured spleen stiffness in 393 patients diagnosed with cirrhosis (based on histologic or physical, laboratory, and radiologic findings) at a hospital in Japan from September 2010 through August 2013 (280 patients with compensated and 113 patients with decompensated cirrhosis). Patients underwent biochemical, ARFI, ultrasonography, and endoscopy evaluations every 3 or 6 months to screen for liver-related complications until their death, liver transplantation, or the end of the study period (October 2015). The primary outcome was the accuracy of spleen stiffness in predicting mortality and decompensation, measured by Cox proportional hazards model analysis. We compared spleen stiffness with other noninvasive parameters using the Harrell's C-index analysis. RESULTS: During a median follow-up period of 44.6 months, 67 patients died and 35 patients developed hepatic decompensation. In the multivariate analysis, spleen stiffness was an independent parameter associated with mortality, after adjustment for levels of alanine aminotransferase and serum sodium, and the model for end-stage liver disease score (P < .001). Spleen stiffness was associated independently with decompensation after adjustment for Child-Pugh score and model for end-stage liver disease score (P < .001). Spleen stiffness predicted mortality and decompensation with greater accuracy than other parameters (C-indexes for predicting mortality and decompensation were 0.824 and 0.843, respectively). A spleen stiffness cut-off value of 3.43 m/s identified the death of patients with a 95.3% negative predictive value and 75.8% accuracy. A spleen stiffness cut-off value of 3.25 m/s identified patients with decompensation with a 98.8% negative predictive value and 68.9% accuracy. CONCLUSIONS: Spleen stiffness, measured by ARFI imaging, can predict death of patients with cirrhosis with almost 76% accuracy and hepatic decompensation with almost 70% accuracy. It might be a useful noninvasive test to predict patient outcome. UMIN Clinical Trials Registry no. UMIN000004363.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Takuma Y, Morimoto Y, Takabatake H, et al. Measurement of Spleen Stiffness With Acoustic Radiation Force Impulse Imaging Predicts Mortality and Hepatic Decompensation in Patients With Liver Cirrhosis. Clin Gastroenterol Hepatol. 2016. PMID: 28017842. doi:10.1016/j.cgh.2016.10.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。